Key Details
Price
$4.29Annual ROE
-1873.17%Beta
3.18Events Calendar
Next earnings date:
Nov 28, 2024Recent quarterly earnings:
Aug 27, 2024Recent annual earnings:
Aug 15, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 15, 2024Analyst ratings
Recent major analysts updates
08 Jan '24 HC Wainwright & Co.
Neutral29 Nov '23 HC Wainwright & Co.
Buy07 Sept '23 Cantor Fitzgerald
Overweight31 Aug '23 Cantor Fitzgerald
Overweight02 Aug '23 HC Wainwright & Co.
Buy01 Aug '23 Cantor Fitzgerald
Overweight01 Dec '22 HC Wainwright & Co.
Buy30 Nov '22 Oppenheimer
Outperform20 Sept '22 HC Wainwright & Co.
Buy07 Mar '22 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Portage Biotech doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024
PRTG
globenewswire.com26 November 2024
WESTPORT, Conn., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today reported its financial results for the fiscal quarter ended September 30, 2024.
FAQ
- What is the primary business of Portage Biotech?
- What is the ticker symbol for Portage Biotech?
- Does Portage Biotech pay dividends?
- What sector is Portage Biotech in?
- What industry is Portage Biotech in?
- What country is Portage Biotech based in?
- When did Portage Biotech go public?
- Is Portage Biotech in the S&P 500?
- Is Portage Biotech in the NASDAQ 100?
- Is Portage Biotech in the Dow Jones?
- When was Portage Biotech's last earnings report?
- When does Portage Biotech report earnings?
- Should I buy Portage Biotech stock now?
What is the primary business of Portage Biotech?
PRTG (Portage Biotech) is a biotechnology company focused on developing innovative treatments for cancer. They work on advanced therapies that target specific cancer cells, aiming to improve patient outcomes. PRTG combines scientific research with clinical development to bring new solutions to the healthcare market.
What is the ticker symbol for Portage Biotech?
The ticker symbol for Portage Biotech is NASDAQ:PRTG
Does Portage Biotech pay dividends?
No, Portage Biotech does not pay dividends
What sector is Portage Biotech in?
Portage Biotech is in the Healthcare sector
What industry is Portage Biotech in?
Portage Biotech is in the Biotechnology industry
What country is Portage Biotech based in?
Portage Biotech is headquartered in British Virgin Islands
When did Portage Biotech go public?
Portage Biotech's initial public offering (IPO) was on 02 January 2002
Is Portage Biotech in the S&P 500?
No, Portage Biotech is not included in the S&P 500 index
Is Portage Biotech in the NASDAQ 100?
No, Portage Biotech is not included in the NASDAQ 100 index
Is Portage Biotech in the Dow Jones?
No, Portage Biotech is not included in the Dow Jones index
When was Portage Biotech's last earnings report?
Portage Biotech's most recent earnings report was on 27 August 2024
When does Portage Biotech report earnings?
The next expected earnings date for Portage Biotech is 28 November 2024
Should I buy Portage Biotech stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions